Abiopharma

Lincoln National Corporation’s Board of Directors Declares Quarterly Cash Dividend & Announces Plans to Resume Share Repurchases in the Third Quarter of 2026

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

Silvia Outperforms Every Major AI Model on Tax and Open Sources the Benchmark Test

Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update

Aben Gold Commences Drill Program at Justin Gold Tungsten Project

McChip Provides Corporate Update

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Bitdeer Reports Unaudited Financial Results for the Second Quarter of 2026

UL Solutions to Attend Upcoming Investor Conferences

Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency